Pharmacy prescribing and contraception access
March 26, 2010 by admin
The author argues that it is unlikely that schemes to make oral hormonal contraception available through pharmacy prescribing will contribute to a reduction in teenage pregnancies, and highlights all the other issues, as well as access, that are part of this problem. For example, the pilot schemes are unlikely to include under-16s, and if compliance is poor encouraging more women to take oral contraceptives rather than use other methods could result in more pregnancies.
Hand H. Widening access to contraception: the impact of pharmacy prescribing. Nurse Prescribing 2010; 8(2): 58-65.
Categories
Recent Posts
- Oral penicillin: children’s dosage recommendations
- RCN indemnity changes - further reactions
- No news is bad news on CD changes
- Where is the evidence base: NMP in primary care?
- Medicines for Children website launched
- NRLS to transfer to NHS Trust
- RCN indemnity changes
- Medicines legislation to be consolidated
- ANP annual conference: diversity, change and standards
- CD changes promised by end of October
Tags
- ANP ANP conference Carey N CD children CKS Clinical Knowledge Summaries consultation controlled drugs COPD cosmetic treatments Courtenay Courtenay M CPD dermatology DH diabetes district nurse prescriber generic substitution Home Office independent prescribers Matt Griffiths mental health MeReC MHRA Misuse of Drugs mixing medicines National Prescribing Centre NICE NMC non-medical prescribing NPC NPF NPSA Nurse prescribing Patient Group Directions PGD PGDs Prescribing RCN Royal Pharmaceutical Society Stenner Stenner K supplementary prescribers unlicensed medicines
